| Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer I Honma, H Kitamura, T Torigoe, A Takahashi, T Tanaka, E Sato, ... Cancer immunology, immunotherapy 58, 1801-1807, 2009 | 83 | 2009 |
| Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract H Kitamura, T Torigoe, Y Hirohashi, H Asanuma, R Inoue, S Nishida, ... Modern Pathology 26 (1), 117-124, 2013 | 68 | 2013 |
| Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts N Kohei, T Tanaka, K Tanabe, N Masumori, N Dvorina, A Valujskikh, ... Kidney international 89 (6), 1293-1306, 2016 | 67 | 2016 |
| Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan M Hirobe, T Tanaka, T Shindo, K Ichihara, H Hotta, A Takahashi, R Kato, ... International Journal of Clinical Oncology 23, 734-741, 2018 | 64 | 2018 |
| Long-term functional outcome and late complications of Studer's ileal neobladder T Tanaka, H Kitamura, A Takahashi, N Masumori, N Itoh, T Tsukamoto Japanese journal of clinical oncology 35 (7), 391-394, 2005 | 58 | 2005 |
| Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival C Purroy, RL Fairchild, T Tanaka, WM Baldwin III, J Manrique, JC Madsen, ... Journal of the American Society of Nephrology 28 (8), 2377-2392, 2017 | 55 | 2017 |
| Potential Survival Benefit of Anti‐Apoptosis Protein: Survivin‐Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent … T Tanaka, H Kitamura, R Inoue, S Nishida, A Takahashi-Takaya, ... Journal of Immunology Research 2013 (1), 262967, 2013 | 48 | 2013 |
| Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma T Tanaka, T Torigoe, Y Hirohashi, E Sato, I Honma, H Kitamura, ... Journal of cancer research and clinical oncology 140, 503-513, 2014 | 47 | 2014 |
| Current approach to diagnosis and management of retroperitoneal fibrosis T Tanaka, N Masumori international Journal of Urology 27 (5), 387-394, 2020 | 44 | 2020 |
| Prostate cancer stem‐like cells/cancer‐initiating cells have an autocrine system of hepatocyte growth factor S Nishida, Y Hirohashi, T Torigoe, R Inoue, H Kitamura, T Tanaka, ... Cancer science 104 (4), 431-436, 2013 | 42 | 2013 |
| Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma E Sato, T Torigoe, Y Hirohashi, H Kitamura, T Tanaka, I Honma, ... Clinical Cancer Research 14 (21), 6916-6923, 2008 | 38 | 2008 |
| Incidence and risk factors of postoperative delirium in elderly patients undergoing urological surgery: a multi‐institutional prospective study M Matsuki, T Tanaka, A Takahashi, R Inoue, H Hotta, N Itoh, K Taguchi, ... International Journal of Urology 27 (3), 219-225, 2020 | 35 | 2020 |
| Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical … T Shindo, N Masumori, H Kitamura, T Tanaka, F Fukuta, T Hasegawa, ... World journal of urology 32, 1281-1285, 2014 | 34 | 2014 |
| A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy H Kitamura, M Igarashi, T Tanaka, T Shindo, N Masumori, M Tamakawa, ... Japanese journal of clinical oncology 42 (12), 1192-1196, 2012 | 34 | 2012 |
| Anti‐huCD20 antibody therapy for antibody‐mediated rejection of renal allografts in a mouse model T Abe, D Ishii, V Gorbacheva, N Kohei, H Tsuda, T Tanaka, N Dvorina, ... American Journal of Transplantation 15 (5), 1192-1204, 2015 | 33 | 2015 |
| Paclitaxel, ifosfamide, and nedaplatin as second‐line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group H Kitamura, K Taguchi, Y Kunishima, M Yanase, A Takahashi, M Shigyo, ... Cancer science 102 (6), 1171-1175, 2011 | 33 | 2011 |
| Human leukocyte antigen class I down‐regulation in muscle‐invasive bladder cancer: its association with clinical characteristics and survival after cystectomy I Homma, H Kitamura, T Torigoe, T Tanaka, E Sato, Y Hirohashi, ... Cancer science 100 (12), 2331-2334, 2009 | 33 | 2009 |
| Retroperitoneoscopic nephrectomy of a horseshoe kidney with renal-cell carcinoma H Kitamura, T Tanaka, D Miyamoto, H Inomata, JI Hatakeyama Journal of endourology 17 (10), 907-908, 2003 | 32 | 2003 |
| Cytomegalovirus infection following renal transplantation in patients administered low‐dose rituximab induction therapy H Nishida, H Ishida, T Tanaka, H Amano, K Omoto, H Shirakawa, ... Transplant International 22 (10), 961-969, 2009 | 30 | 2009 |
| In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection T Yagisawa, T Tanaka, S Miyairi, K Tanabe, N Dvorina, WM Yokoyama, ... Kidney international 95 (2), 350-362, 2019 | 29 | 2019 |
